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Background: Clinical studies showed the contribution of viral infection to the development of asthma. Although
mast cells have multiple roles in the pathogenesis of allergic asthma, their role of in the virus-associated
pathogenesis of asthma remains unknown. Most respiratory viruses generate double-stranded (ds) RNA during their
replication. dsRNA provokes innate immune responses. We recently showed that an administration of polyinocinic
polycytidilic acid (poly IC), a mimetic of viral dsRNA, during allergen sensitization augments airway eosinophilia and
hyperresponsiveness in mice via enhanced production of IL-13.
Methods: The effect of poly IC on allergen-induced airway eosinophilia was investigated for mast cell-conserved Kit+/+
mice and -deficient KitW/KitW-v mice. The outcome of mast cell reconstitution was further investigated.
Results: Airway eosinophilia and IL-13 production were augmented by poly IC in Kit+/+ mice but not in KitW/KitW-v mice.
When KitW/KitW-v mice were reconstituted with bone marrow-derived mast cells (BMMCs), the augmentation
was restored. The augmentation was not induced in the mice systemically deficient for TIR domain-containing
adaptor-inducing IFN-β (TRIF) or interferon regulatory factor (IRF)-3, both mediate dsRNA-triggered innate immune
responses. The augmentation was, however, restored in KitW/KitW-v mice reconstituted with TRIF-deficient or
IRF-3-deficient BMMCs. Although leukotriene B4 and prostaglandin D2 are major lipid mediators released from activated
mast cells, no their contribution was shown to the dsRNA-induced augmentation of airway eosinophilia.
Conclusions: We conclude that mast cells contribute to dsRNA-induced augmentation of allergic airway inflammation
without requiring direct activation of mast cells with dsRNA or involvement of leukotriene B4 or prostaglandin D2.
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The pathogenesis of asthma is frequently associated
with airway viral infection. The respiratory sincytial
virus, the rhinovirus, and the parainfluenzae virus are
reported to contribute to the development of asthma
and its acute exacerbation [1,2]. These viruses have
single-stranded RNA as their own genome and then
generate double-stranded (ds)RNA following infection
to their host cells, as an intermediate for replication.
Given that dsRNA, longer than 30 base pairs, provokes* Correspondence: koichi@kokyu.med.kyushu-u.ac.jp
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reproduction in any medium, provided the orinnate immune responses in mammalian cells, it is a ra-
tional approach to target dsRNA for elucidating the
common mechanisms of the virus-associated pathogen-
esis of asthma. We have shown that a low-dose (10 μg/
mouse) administration of polyinocinic polycytidilic acid
(poly IC), a mimetic of viral dsRNA, during allergen
sensitization in mice markedly augments airway eosino-
philia and airway hyperresponsiveness (AHR), cardinal
phenotypes of allergic asthma [3].
It is well known that mast cells have multiple roles in
the pathogenesis of allergic diseases including asthma.
Mast cells activated by an allergen/IgE/ FcεR1 cross-
linking produce a variety of chemical mediators,
chemokines, and cytokines. These compounds mediatetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adaptive immune responses. In addition, mast cells are
highly effective sentinels and have been shown to take
part in innate immune responses to a variety of patho-
gens [4,5]. Although accumulating knowledge leads to a
hypothesis that mast cells play a pivotal role in the
virus-associated pathogenesis of asthma, there has been
no experimental evidence to support the above hypoth-
esis. In the present study, we sought to investigate
whether mast cells contribute or not to the dsRNA-
induced augmentation of asthma phenotype. To this
end, we examined the effect of poly IC on an asthma
phenotype for mast cell-conserved and -deficient mice
and further investigated the outcome of mast cell
reconstitution.
Methods
Preparation of poly IC
Poly IC (Sigma Aldrich) was dissolved into physiological
saline at the final concentration of 100 μg/ml and tested
for endotoxin activity by the Limulus HS-T single Test™
(Wako Pure Chemical) with a resolution limit of 0.008
EU (endotoxin units)/ml. The activity of endotoxin was
under the detection limit.
Animals
All experimental procedures were approved by the ani-
mal research ethics committee of Kyushu University
(reference number: A23-048-1). BALB/c and C57BL/6
mice were purchased from Charles River Japan. Mast
cell-deficient (KitW/KitW-v) and mast cell-conserved
(Kit+/+) mice were purchased from SLC Japan. TRIF−/−and
IPS-1−/−mice on a C57BL/6 background kindly provided
by Dr. Shizuo Akira (the Research Institute for Microbial
Diseases, Osaka University, Osaka, Japan). IRF-3−/−mice on
a C57BL/6 background were kindly provided by Tadatsugu
Taniguchi (the Department of Immunology, Graduate
School of Medicine and Faculty of Medicine, University of
Tokyo, Japan). BLT-1−/− mice on a BALB/c background
were generated at the Department of Biochemistry, Faculty
of Medicine, Kyushu University (Fukuoka, Japan).
Hematopoietic PGD2 synthase (hPGD2S)
−/−mice on a
C57BL/6 background were generated at the Osaka Bio-
science Institute (Osaka, Japan). Mice were housed under
specific pathogen-free conditions until 6–7 wk of age.
Sensitization and challenge
Mice were sensitized by an i.p. injection of 10 μg of OVA
(Sigma-Aldrich) and 0.3 mg of Al(OH)3 (SERVA Electro-
phoresis) on days 1 and 14 and challenged with 1% OVA
in saline mist for 20 min on days 26, 27, and 28, as de-
scribed previously [3]. Outcome measurements were con-
ducted on day 30 (2 wk interval protocol). Subgroups of
KitW/KitW-v and Kit+/+ mice were sensitized on days 1 and14 and challenged with OVA on days 54, 55, and 56, and
measurements were conducted on day 58 (6 wk interval
protocol). Mice received an i.p. injection of 10 μg of poly
IC 1 h before each OVA sensitization. Mice receiving
physiological saline served as controls. For hPGDS inhib-
ition, mice received an administration of 30mg/kg of
HQL-79, an orally selective inhibitor of hPGD2S (Cayman-
Chemical) or its vehicle solution 1 h before each poly IC
treatment. To assess the acute effect of dsRNA, naive mice
were sacrificed and their blood was sampled 5 h after a sin-
gle injection with poly IC.Reconstitution of mast cells
Bone marrow-derived mast cells (BMMCs) were generated
by cultivation of bone marrow cells from C57BL/6 mice,
TRIF−/−mice, IRF-3−/−mice, or hPGDS−/− mice in the pres-
ence of recombinant murine IL-3 at 5 ng/ml. Cells we-
re maintained in an Iscove modified Dulbecco medium
(IMDM, PAA) containing 10% FCS (Sigma-Aldrich), 50
mM β-mercaptoethanol, nonessential amino acid, 2mML-
glutamine, 100U/ml penicillin, 100mg/ml streptomycin,
and 1mM sodium pyruvate (all from Gibco BRL). After
4wk of culture, BMMCs represented more than 98% of the
total cells, according to a flow cytometric analysis of the ex-
pression of CD117 (c-Kit) and FcεR1. Seven week-old
KitW/KitW-v mice were reconstituted with an i.p. injection
of 6 × 106 BMMCs and processed for OVA-sensitization/
challenge 5 wk after the transfer. The reconstitution of mast
cells in the peritoneum was confirmed by flow cytometric
detection of GFP-positive cells in the peritoneal lavage fluid
of the mice following transfer of BMMCs from systemic
GFP-labeled C57BL/6mice. The reconstitution of mast
cells in the lung was confirmed by microscopic detection of
toluidine blue-stained mast cells in the airway mucosal tis-
sues of the mice following transfer of BMMCs.Measurement of airway hyperresponsiveness (AHR)
Mice were anesthetized with a mixture of ketamine and
sodium pentobarbital i.p., and their tracheas were can-
nulated via tracheostomy. Animals were ventilated to
measure airway responsiveness to acetylcholine aerosol,
as described previously [6]. The data were expressed as
the provocative concentration 200 (PC200), i.e., the con-
centration at which airway pressure was 200% of its
baseline value. The values of PC200 were expressed as
log (PC200 × 100).Bronchoalveolar lavage
Immediately after blood sampling, mice were exan-
guinated and their lungs were lavaged with 1 ml of
physiological saline via a tracheal cannula. Cell counts
were performed as previously described [6]. Samples
Kan-o et al. Respiratory Research 2013, 14:28 Page 3 of 9
http://respiratory-research.com/content/14/1/28were centrifuged at 2000 rpm for 10 min, and the su-
pernatants were collected for cytokine ELISA.Determination of cytokine concentration
IL-13 in the supernatants of bronchoalveolar lavage fluid
(BALF) and IL-6 and IFN-β in the serum were quanti-
fied using ELISA kits (BioSource, or R&D Systems).Collection of lung cells
Lungs were cut and minced. Complete RPMI 1640 (Gibco
BRL) containing 10% FCS (Sigma-Aldrich), 100 U/ml
penicillin, and 100mg/ml streptomycin was added to the
minced lungs and incubated for 60 min. The samples were
filtered through a cell strainer (BD Falcon). The single-cell
suspensions were washed with complete RPMI 1640, and
the erythrocytes were lysed with an NH4Cl-Tris buffer.
Cells were suspended in complete RPMI.Intracellular cytokine flow cytometry
Whole lung cells (4 × 106 cells/well) were stimulated
with plate-coated anti-mouse CD3 mAb (clone: 145-
2C11) at 5 μg/ml plus soluble anti-mouse CD28 mAb
(clone: 37.51) at 2 μg/ml for 48 hr. Golgi-Stop (BD Bio-
sciences) was added for the last 6 h of stimulation. The
unadherent cells were harvested and preincubated with
Fc Block (BD biosciences) and surface staining was
performed using peridinin chlorophyll protein (PerCP)-
labeled anti-mouse CD4 (clone: RM4-5) or anti-mouse
CD8α (clone: 53–6.7) and allophycocyanin-labeled anti-
mouse CD3 (clone: 145-2C11) mAbs. Intracellular
staining was performed using a commercially available
kit (eBioscience). The cells were fixed with a fixation buf-
fer for 20 min. After a wash, cells were suspended in a
permeabilization buffer with 5% normal rat serum
(COSMO BIO) for 10 min, and biotinylated anti-mouse
IL-13 Ab or control IgG (R&D Systems) was added for
30 min. After a wash with a permeabilization buffer, cells
were incubated in the presence of phycoerythrin (PE)-la-
beled streptavidin (BD Biosciences) for 30 min. After
washes, samples were assessed using a FACSCalibur (BD
Biosciences). All antibodies, except for anti-IL-13, were
purchased from BD Bioscineces.Data analysis
Values are expressed as the mean ± SEM. Parametric
data were analyzed using the unpaired t test or an
ANOVA with Bonferroni’s correction. Non-parametric
data were analyzed using the Mann–Whitney U test or
the Kruskal-Wallis test. P-values less than 0.05 were ac-
cepted as statistically significant.Results
Mast cells contribute to dsRNA-induced augmentation of
airway eosinophilia and IL-13 production
In our previous study, an administration of poly IC (10 μg/
mouse) during OVA sensitization augmented airway eo-
sinophilia and AHR in OVA-challenged BALB/c mice [3].
These augmented asthma phenotypes were associated with
enhanced production of IL-13. Given that Kit+/+ mice and
KitW/KitW-v mice are generated on the WB × C57B6 F1
background, the effect of poly IC on the asthma pheno-
types was examined for C57BL/6 mice. When the mice
were treated with poly IC 1 h before each sensitization with
OVA (Figure 1A), the eosinophilia in BALF after OVA in-
halation challenge was augmented significantly more than
those in saline-treated mice. On the other hand, AHR was
not affected by the treatment with poly IC. Hence, the ef-
fect of poly IC on asthma phenotype was evaluated by
eosinophilia in BALF for the subsequent experiments. The
eosinophilia in BALF was significantly augmented by poly
IC in mast cell-conserved Kit+/+ mice but not in mast cell-
deficient KitW/KitW-v mice (Figure 1B). When KitW/KitW-v
mice were reconstituted with BMMCs from C57BL/6 mice
in advance, the augmentation of eosinophilia in BALF was
restored (Figure 1C). Of note, eosinophilia in BALF was
significantly augmented not only in Kit+/+ mice but also
in KitW/KitW-v mice when a longer interval than that des-
cribed above, 6 wks versus 2 wks after the second
sensitization, had been used prior to the OVA challenge
(Figure 1D). This finding indicates that mast cells might not
be essential for the augmentation of asthma phenotype but
strongly promote it. The concentration of IL-13 in BALF in
poly IC-treated Kit+/+ mice was significantly higher than
that in saline-treated Kit+/+ mice, while the concentration of
IL-13 in poly IC-treated KitW/KitW-v mice was not different
from that in saline-treated KitW/KitW-v mice (Figure 1E).
After the reconstitution with BMMCs, the concentration of
IL-13 in poly IC-treated KitW/KitW-v mice was significantly
higher than that in saline-treated KitW/KitW-v mice. In
Kit+/+ mice, the numbers of IL-13-producing CD4+ and
CD8+ T cells in the lungs of poly IC-treated mice were sig-
nificantly larger than those of saline-treated mice (Figure 1F).
In KitW/KitW-v mice, however, the numbers of IL-13-pro-
ducing CD4+ and CD8+ T cells were comparable between
poly IC-treated mice and saline-treated mice. These results
suggest that mast cells contribute to dsRNA-induced aug-
mentation of airway eosinophilia and production of IL-13.
The TRIF-IRF-3 pathway is essential for dsRNA-induced
augmentation of airway eosinophilia
In the innate immune systems, dsRNA is recognized via
pattern recognition receptors (PRRs), such as TLR3
and the family of RNA helicase, namely the reti-
noic acid-inducible gene I (RIG-I) and melanoma dif-
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Figure 1 (See legend on next page.)
Kan-o et al. Respiratory Research 2013, 14:28 Page 4 of 9
http://respiratory-research.com/content/14/1/28
(See figure on previous page.)
Figure 1 Effect of poly IC on allergen-induced airway eosinophilia in mast cell-conserved and –deficient mice. (A) C57BL/6 mice were treated
with poly IC (black bar and circle) or saline (gray bar and circle) one hour before each sensitization with OVA. Non-sensitized/challenged mice served as
naive controls (white bar and circle). Two weeks later, mice were challenged with OVA, and the mice were challenged with OVA, and the eosinophilia in
BALF and the airway hyperresponsiveness were measured. The data of airway hyperresponsiveness were expressed as the provocative concentration 200
(PC200). The values of PC200 were expressed as log (PC200 × 100). (B) Mast cell-conserved Kit
+/+ mice or deficient KitW/KitW-v mice were treated with poly
IC or saline before sensitization. Two weeks later, the mice were challenged with OVA, and the eosinophilia in BALF was measured. (C) KitW/KitW-v mice
were transferred with or without BMMCs from C57BL/6 mice. Five weeks later, the mice were treated with poly IC or saline before sensitization. Two
weeks later, mice were challenged with OVA, and the eosinophilia in BALF was measured. (D) KitW/KitW-v mice were transferred with or without BMMCs
from C57BL/6 mice. Five weeks later, mice were treated with poly IC or saline before. Six weeks later, mice were challenged with OVA, and the
eosinophilia in BALF was measured. (E) Kit+/+ mice, KitW/KitW-v mice, and BMMC-transferred KitW/KitW-v mice were treated with poly IC or saline before
sensitization. Two weeks later, the mice were challenged with OVA, and IL-13 was measured by ELISA. (F) Kit+/+ mice and KitW/KitW-v mice were treated
with poly IC or saline before OVA sensitization. Two weeks later, mice were challenged with OVA, and IL-13-producing CD4+ and CD8+T-cell subsets in
the lungs were enumerated. Data are expressed as the means ± SEM. Each group consisted of five to nine mice.
*P < 0.05 between the indicated two groups. NS means statistically no significant.
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ing through an adaptor, the Toll/IL-1R domain-
containing adaptor inducing IFN-β (TRIF) (also known
as TICAM-1) [11,12]. RIG-I and Mda5 recognize
dsRNA in the cytoplasm and initiates signaling through
IFN-β promoter stimulator 1 (IPS-1) (also known as
MAVS/Cardif/VISA) [13-16]. The dsRNA/PRRs inter-
action initiates cascades to produce type-I IFNs and
proinflammatory cytokines including IL-6 [17]. Both
TRIF and IPS-1 share interferon regulatory factor
(IRF)-3 as their downstream transcriptional factor for
the production of type-I IFNs [18]. The effects of poly
IC on the innate immune responses were compared
among TRIF−/−mice, IPS-1−/−mice, IRF-3−/−mice, and
wild-type C57BL/6 mice. The concentrations of IFN-β
and IL-6 in the sera were assessed 5 h after a single i.p.
injection of poly IC to their naive mice (Figure 2A).
The injection significantly increased the concentrations
of IFN-β and IL-6 in wild-type mice and IPS-1−/−mice
but not in TRIF−/−mice or IRF-3−/−mice. Next, the ef-
fect of poly IC on airway eosinophilia was evaluated. In
wild-type mice and IPS-1−/−mice, the poly IC treatment
significantly augmented the eosinophilia in BALF, but it
did not in TRIF−/−mice or IRF-3−/−mice (Figure 2B),
suggesting that the TRIF-IRF-3 pathway is es-
sential for the poly IC-induced augmentation of air-
way eosinophilia.
Direct activation of mast cells with dsRNA is not required
for augmentation of airway eosinophilia
Given the essential role of the TRIF-IRF-3 pathway in the
poly IC-induced augmentation, we sought to explore
whether this pathway needs to work in mast cells. KitW/
KitW-v mice were reconstituted with BMMCs from
TRIF−/−mice, IRF-3−/−mice or wild-type mice and then
treated with poly IC during sensitization (Figure 3). Fol-
lowing the OVA challenge, the augmentation of
eosinophilia in BALF was restored not only in the mice
reconstituted with BMMCs from wild-type mice but alsoin those with BMMCs from TRIF−/−mice or IRF-3−/−mice.
Hence, direct activation of mast cells with poly IC via the
TRIF-IRF-3 pathway is not required for the augmentation.
dsRNA-induced augmentation of airway eosinophilia is
independent of mast cell-derived prostaglandin D2 or
leukotriene B4
Previous studies showed that mast cells induce the recruit-
ment of IL-13-producing T cells into the airway via releas-
ing leukotriene B4 (LTB4), a potent chemoattractant for
several subsets of T cells by its binding to the high-affinity
receptor, BLT1 [19,20]. In BLT1
−/− mice, however, the eo-
sinophilia in BALF was significantly augmented by poly IC
similarly as it was in wild-type mice (Figure 4A). Several
studies have shown that prostaglandin D2 (PGD2) and its
receptors DP and CRTH2 are involved in the pathogenesis
of asthma [21-23]. PGD2 is a major prostanoid being
released from mast cells, which is dependent on the activa-
tion of hPGD2S [24]. To elucidate whether the poly IC-
induced augmentation of airway eosinophilia depends on a
mechanism via mast cell-derived PGD2, the effect of poly
IC was examined for KitW/KitW-v mice that had been
reconstituted with BMMCs from hPGD2S
−/−mice (Figure
4B) [25]. The poly IC treatment significantly augmented
the eosinophilia in BALF in the mice reconstituted with
hPGD2S
−/−mice-derived mast cells, as it did in those with
wild-type mice-derived mast cells. Next, the effect of the
poly IC was tested in wild-type mice that received HQL-79,
an orally selective inhibitor of hPGD2S [26], before each
OVA sensitization (Figure 4C). The administration of
HQL-79 failed to prevent the augmentation of the eosino-
philia in BALF. Taken together, poly IC-induced augmenta-
tion of asthma eosinophilia may be independent of mast
cell-derived PGD2 or LTB4.
Discussion
In the present study, the mice were sensitized with OVA
emulsified with alum. A previous study showed that mast


































Figure 3 Effect of TRIF/IRF-3 deficiency in mast cells on poly
IC-induced augmentation of airway eosinophilia. KitW/KitW-v mice
were transferred with BMMCs from C57BL/6 mice, TRIF−/−mice, or
IRF-3−/−mice. Five weeks after the transfer, mice were treated with
poly IC or saline alone before each OVA sensitization. Two weeks
later, the mice were challenged with OVA, and the eosinophilia in
BALF was measured. Each group consisted of five to eight mice.
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Figure 2 Role of TRIF, IPS-1, and IRF-3 in poly IC-induced
augmentation of airway eosinophilia. (A) Naive C57BL/6 mice,
TRIF−/−mice, IPS-1−/−mice, and IRF-3−/−mice were treated with poly
IC. The sera were collected five hours after poly IC, and the IFN-β and
IL-6 contents were then measured by ELISA. Each group consisted of
five to nine mice. (B) C57BL/6 mice, TRIF−/−mice, IPS-1−/−mice, and
IRF-3−/−mice were treated with poly IC or saline alone before each OVA
sensitization. Two weeks later, mice were challenged with OVA, and the
eosinophilia in BALF was measured. Each group consisted of five to
nine mice. Data are expressed as the means ± SEM. *P< 0.05 between
the indicated two groups.
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but not that induced in mice sensitized with OVA with
alum [27]. Indeed, the magnitude of airway eosinophilia in
KitW/KitW-v mice was comparable with that in Kit+/+ mice
in the absence of poly IC treatment. In the presence of
poly IC, eosinophilia, IL-13 in BALF, and the num-
bers of IL-13-producing CD4+ and CD8+ T cells were aug-
mented in Kit+/+ mice but not in KitW/KitW-v mice. After
mast cell reconstitution, eosinophilia and IL-13 in BALF
were augmented by poly IC treatment even in KitW/
KitW-v mice. These findings indicate that mast cells may
specifically contribute to dsRNA-induced augmentation of
airway eosinophilia via amplifying the production of IL-13.The limitation of this study is that we could not clarify
when mast cells played their promoting role, whether in
sensitization phase or challenge phase. No difference
in the effect of poly IC on airway eosinophilia bet-
ween Kit+/+ and KitW/KitW-v mice in 6 wk interval proto-
col made it difficult to investigate the effect of BMMC
transfer after the sensitization phase on asthma pheno-
type. According to this limitation, the subsequent exami-
nations were designed in consideration with both cases.
A mast cell is a highly effective sentinel and has been
shown to take part in innate immune responses to a var-
iety of pathogens [4,5]. Human and murine mast cells
express TLR3, which are capable of producing a broad
spectrum of mediators in response to dsRNA [28,29]. A
previous study reported that CD8+ T-cell recruitment
induced by an i.p. injection of poly IC is impaired in
KitW/KitW-v mice with compared to Kit+/+ mice and that
poly IC-stimulated BMMCs have a chemoattractant ac-
tivity for CD8+ T cells in vitro [30]. We have confirmed
that stimulation of BMMCs with poly IC at 3 μg/ml
for 5 h significantly enhanced the production of MIP-
1α, MIP-1β, and eotaxin (unpublished observation). MIP-
1α and MIP-1β preferentially attract CD8+ and CD4+
T cells, respectively [31,32]. However, the augmentation
of airway eosinophilia was restored in the mi-
ce reconstituted with BMMCs from TRIF−/−mice or
IRF-3−/−mice. These results suggest that direct activa-
tion of mast cells with dsRNA is not required for the
augmentation if they play a role in sensitization phase.
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Figure 4 No involvement of prostaglandin D2- or leukotriene
B4 on poly IC-induced augmentation of airway eosinophilia.
The eosinophilia in BALF after OVA challenge was measured for the
mice sensitized with OVA in the following conditions (A to C). OVA
challenge was performed two weeks after the last OVA sensitization.
(A) Wild-type BALB/c mice and BLT-1−/− mice were treated with poly
IC or saline alone before each OVA sensitization. (B) KitW/KitW-v mice
were transferred with BMMCs from wild-type C57BL/6 mice or
hPGD2S
−/−mice. Five weeks after the transfer, mice were treated
with poly IC or saline alone before each OVA sensitization. (C) BALB/c
mice were treated with poly IC or saline alone before each OVA
sensitization. HQL-79, a selective inhibitor of hPGD2S, was
administered just before each poly IC treatment. Data are expressed
as the means ± SEM. Each group consisted of six mice. *P < 0.05
between the indicated two groups.
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tion. Several investigators showed that the migra-
tion of dendritic cell subsets into draining lymph nodes
are partially dependent on mast cells and associa-
ted compounds, including histamine, IL-6, and TNF-α
[33,34]. These indirect processes might be involved in the
dsRNA-induced augmentation of airway eosinophilia. The
determination of underlying mechanisms awaits further
investigation.
The role of mast cells in challenge phase is tightly as-
sociated with the adaptive immune responses. A sub-
population of Th2 cells preferentially expresses
CRTH2, a PGD2 receptor mediating chemotaxis [35].
PGD2 induces the production of macrophage-derived
chemokine (MDC) from airway epithelium, which can
recruit CCR4-expressing Th2 cells in mice [36]. In
addition, effector CD8+ T cells preferentially express a
chemotactic receptor, BLT1 [37,38]. Given that mast
cells activated by an IgE-dependent mechanism pro-
duce ample of PGD2 and LTB4, it is plausible that mast
cells in the airways may be a major recruiter for Th2
and effector CD8+ T cells [39]. Several investigators
have shown that BLT1 is required for effector CD8
+ T
cell-mediated, mast cell-dependent AHR and inflamma-
tion [19,20,40]. However, poly IC treatment augmented
airway eosinophilia under a mast cell-derived PGD2-
deficient or a BLT1-deficient condition, suggesting that
neither mast cell-derived PGD2 nor BLT1 is responsible
for the dsRNA-induced augmentation of airway eosino-
philia. There is another receptor for LTB4, namely BLT2.
We have recently shown that BLT2 negatively regulates
airway eosinophilia via suppressing the activation of
IL-13-producing CD4+ T cell in OVA-sensitized/
challenged mice [41]. This opposing effect makes it
unlikely that BLT2 is associated with dsRNA-induced
augmentation of airway eosinophilia.
Contrasting to our previous study using BALB/c mice
[3], AHR was not augmented by the treatment with poly
IC. It is well known that C57BL/6 mice show blunt AHR
compared to BALB/c or A/J mice. We confirmed that po-
ly IC treatment significantly augmented IL-13 in BALF
even in OVA-sensitized/challenged C57BL/6 mice (unpub-
lished observation). We previously demonstrated that
intratracheal administration of IL-13 failed to induce AHR
in naïve C57BL/6 mice, whereas the same treatment in-
duced AHR in naïve A/J mice [42]. The difference in the
contribution of IL-13 to AHR might account for the lack of
augmentation in C57BL/6 mice.
The methodology using intraperitoneal injection of
poly IC might limit the interpretation of the results
from this study since it induced mild but substantial
immune responses. Indeed, the concentrations of IFN-β
and IL-6 in the serum were increased 5 h after the in-
jection of poly IC in naïve mice. With this regard,
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physiological aspects of viral infection in the hosts. To
gain convincing evidence, application of intranasal or
intratracheal administration of poly IC for airway
sensitization models is a future challenge.
Conclusions
We conclude that mast cells contribute to dsRNA-induced
augmentation of allergic airway inflammation without re-
quiring direct activation of mast cells with dsRNA or in-
volvement of leukotriene B4 or prostaglandin D2. Further
elucidation of their molecular process will help understand
the mechanism underlying the interaction between a viral
infection and the pathogenesis of asthma.
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